Articles tagged "Kidney/pancreas transplantation"

2022 American Transplant Congress
Outcomes of Primary Simultaneous Pancreas-Kidney Transplants by Induction Agent in the United States
A. Cerise¹, T. Shaker¹, K. Ramanathan¹, S. Jackson², R. Kandaswamy¹, S. Riad³
¹Surgery, University of Minnesota, Minneapolis, MN, ²Analytics, MHealth-Fairview, Minneapolis, MN, ³Medicine, University of Minnesota, Minneapolis, MN
*Purpose: Induction immunosuppression choice for simultaneous pancreas-kidney (SPK) transplants varies widely in the United States. We examined the association between induction agents and outcomes of…
2021 American Transplant Congress
Incidence of Oral Candidiasis in Renal and/or Pancreas Transplant Recipients When Administering Prophylaxis versus No Prophylaxis
L. Von Stein¹, S. Patel¹, L. Wardlow²
¹Transplant, The Ohio State Wexner Medical Center, Columbus, OH, ²Pharmacy, The Ohio State Wexner Medical Center, Columbus, OH
*Purpose: Oropharyngeal candidiasis (OC), or thrush, is a fungal infection associated with immunosuppression post renal and or/pancreas transplant. Currently, the role of prophylactic oral nystatin…
2021 American Transplant Congress
Baseline Levels of Dd-cf Dna After Pancreas Transplantation: Using Dd-cfdna as an Indicator for Pancreas Rejection and Biopsy Avoidance
A. Yoo, I. Qian, A. Riedel, C. Cazac, A. Bartosic, J. S. Bromberg, J. Scalea
Department of Surgery, Division of Transplant, University of Maryland School of Medicine, Baltimore, MD
*Purpose: Donor-derived cell-free DNA (dd-cfDNA) testing, which has been previously validated for monitoring kidney transplant (KTx) rejection, may provide an alternative to pancreas biopsy that…
2021 American Transplant Congress
Significance of Detectable but Unquantifiable Viremias Post Renal Transplantation
M. Chaung, S. Puri, S. Bunin, Z. Mondal, O. Eletta, R. Pelletier, A. Bongu
Robert Wood Johnson University Hospital, New Brunswick, NJ
*Purpose: It is unknown whether the degree of the initial viremia following kidney (KT) or combined kidney-pancreas transplantation (SPKT) correlates with future allograft rejection or…
2021 American Transplant Congress
Donor Derived Cell Free DNA Identifies Rejection in Simultaneous Pancreas Kidney Transplant Recipients
M. Williams¹, S. Ghosh², L. L. Jenkins², M. Hertl¹, S. Saltzberg³, V. Peev³, E. Chan¹, E. Hollinger¹, E. Schadde¹, O. Olaitan¹
¹Department of Surgery, Rush University Medical Center, Chicago, IL, ²CareDx, Inc., Brisbane, CA, ³Department of Internal Medicine, Rush University Medical Center, Chicago, IL
*Purpose: Increased level of donor-derived cell-free DNA (dd-cfDNA) has proven to be a sensitive marker for allograft rejection after solid organ transplant, particularly heart and…
2021 American Transplant Congress
Transplantation of Hepatitis C Positive Kidney and Pancreas Allografts Into Hepatitis C Naïve Recipients – A Single Center Experience as a Standard of Care
K. Yadav¹, A. Padiyar², K. Zhao³, J. Rabets³, A. Jittirat², S. Sclair⁴
¹Transplant Surgery, University of Toledo Medical Center, Toledo, OH, ²Nephrology, University Hospitals Cleveland, Cleveland, OH, ³Transplant Surgery, University Hospitals Cleveland, Cleveland, OH, ⁴Gastroenterology and Hepatology, University Hospitals Cleveland, Cleveland, OH
*Purpose: Transplantation of Hepatitis C positive organs into Hepatitis C naïve recipients is rapidly gaining widespread acceptance. We report our experience with transplanting HCV D+/R-…
2021 American Transplant Congress
Unclear Implications of Tacrolimus Time in Therapeutic Range as a Predictor of Acute Rejection in Renal Transplant Recipients Undergoing Early Corticosteroid Withdrawal
D. Pierce, P. West-Thielke, Z. Hajjiri, S. Gaitonde, I. Tzvetanov, E. Benedetti, A. Lichvar
University of Illinois at Chicago, Chicago, IL
*Purpose: Tacrolimus (TAC) demonstrates a wide intra- and inter-patient variability (IPV) necessitating therapeutic drug monitoring. The purpose of this study is to determine the impact…
2021 American Transplant Congress
Superior Metabolic Function of Type 2 Diabetes Mellitus Patients After Simultaneous Kidney/pancreas Transplantation Compared with Kidney Transplantation Alone
X. Y. Fu, C. Yu, H. Wang, J. Zhao, Z. Wang, C. Mo, X. Shi, G. Feng, W. Song, Z. Shen
Tianjin First Centeral Hospital, Tianjin, China
*Purpose: To compare the renal function, metabolic profiles and survival outcomes of simultaneous pancreas kidney transplantation (SPK) and kidney transplantation alone (KTA) to end-stage renal…
2021 American Transplant Congress
The Impact of Lack of Access to Simultaneous Kidney and Pancreas Transplantation Due to Insurance Ineligibility – A Single Center Analysis
Y. A. Qazi, E. Villalon, D. Samson, W. Mon, M. Smogorzewski
Keck Medical Center at USC, Los Angeles, CA
*Purpose: Simultaneous kidney and pancreas transplantation(SPK) provides a survival and quality of life advantage in young, low BMI insulin dependent diabetics with End Stage Renal…
2021 American Transplant Congress
Deceased Donor Transplantation Across Positive Flow Crossmatch – A Single Center Experience
M. Campara, A. Lichvar, J. Benken, S. Patel, C. Muran, D. Pierce, I. Tang, P. Di Cocco, J. Almario Alvarez, M. Spaggiari, E. Benedetti, I. Tzvetanov
University of Illinois at Chicago, Chicago, IL
*Purpose: Transplantation across a positive flow crossmatch (+FXM) has been established as a lifesaving measure in the living donor setting. Time required for desensitization limits…